Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

AIM Rule 17 Update

9 Feb 2023 08:33

RNS Number : 4431P
Versarien PLC
09 February 2023
 

 

 

 

9 February 2023

 

Versarien plc

("Versarien" or the "Company")

AIM Rule 17 Update

 

Versarien plc (AIM: VRS), the advanced materials engineering group, provides the following update in accordance with its disclosure obligations required under Rule 17 of the AIM Rules for Companies.

 

In a correction to the announcement of 7 January 2021, the Company advises that Dr Stephen Hodge, Chief Technology Officer, holds a beneficial interest in 46,774 ordinary shares of 1 pence each in the Company, acquired as part of Versarien's acquisition of Cambridge Graphene Limited in January 2017.

 

 

For further information please contact:

 

Versarien Plc

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 887204

Chris Leigh - Chief Financial Officer

Stephen Hodge - Chief Technology Officer

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Adam Cowl

+44 (0) 20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

+44 (0) 20 3207 7800

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien Plc

 

The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.

 

For further information please see: https://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKOWRORUURRR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.